A new study indicates there are persistent socioeconomic disparities in the rates of women who receive breast reconstruction surgery after undergoing a mastectomy to treat their breast cancer.
A new study indicates there are persistent socioeconomic disparities in the rates of women who receive breast reconstruction surgery after undergoing a mastectomy to treat their breast cancer.
Post mastectomy reconstruction is widely recognized as “a critical component of comprehensive, high-quality breast cancer care,” as it can improve women’s quality of life after breast cancer treatment, according to the study published in Annals of Surgical Oncology.
Despite policies meant to encourage plastic surgery consultations and provide insurance coverage of reconstruction, the surgery is not universal among all breast cancer survivors after a mastectomy. While some cases of skipped reconstruction are due to patient preference or clinical characteristics, the study authors hypothesized that socioeconomic status (SES) may also play a role in who receives reconstruction after a mastectomy.
Using the National Cancer Database, researchers identified nearly 300,000 women who had their stage 0 or 1 breast cancer treated with mastectomy between 2004 and 2013. The database included information on immediate breast reconstruction, as well as sociodemographic factors (eg, race, education, insurance, median household income, and urban/rural location) and clinical characteristics.
Across the entire study period, the cohort-wide rate of reconstruction was 40%; it had risen from 27% in 2004 to 48% in 2013. Women were most likely to receive reconstruction if they were white, had private insurance, and lived in areas with high rates of high school education (64.2% of these women received reconstruction).
In contrast, patients with Medicaid who lived in areas with the lowest high school graduation rates were least likely to undergo reconstruction. The odds of reconstruction for these patients were 45.7% for white women and 42.4% for black women. The researchers also determined that the gap in reconstruction across SES strata persisted across the study period, even though the absolute rate of reconstruction increased over time for all groups.
“Although the increases in the rate of immediate breast reconstruction observed in our study are promising, the ongoing disparities in the receipt of reconstruction for socioeconomically disadvantaged patients is significant,” the study authors wrote.
Based on theories of behavior change, the researchers suggested that these disparities arise from differences in patients’ capability, motivation, and opportunity to undergo reconstruction. For instance, patients without the education needed to ask their providers about reconstruction options would lack the capability, while patients who could not afford to take time off from work would not have the opportunity to receive this beneficial surgery.
Considering this complex interplay of factors, interventions to reduce the socioeconomic disparities in reconstruction must address the patient-level, provider-level, and systemic causes.
“Understanding how socioeconomic factors influence receipt of immediate reconstruction and determining which are modifiable critical next steps towards identifying interventions that will improve the quality of breast cancer surgical care for disadvantaged populations,” the authors concluded.
Congress Urged to Repeal Comstock Act Threatening Reproductive Rights and Public Health
May 16th 2024In a joint letter addressed to Congress, Healthcare Across Borders, Take Back the Court Action Fund, and UltraViolet Action called out the resurgence of the Comstock Act, urging immediate action to repeal this century-old law that threatens reproductive rights and public health in the US.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Access Denied: CMS’ Action Hurts Patients With Cancer in Rural America
May 6th 2024CMS rules hindered the access of rural patients with cancer to medically integrated pharmacies in 2023. The authors discuss the impact on equity in health care, emphasizing the need for regulatory change.
Read More
Shelly Lanning on How Employers Can Reduce Costs by Bridging Gaps in Women's Health Care
May 3rd 2024In a presentation at the Greater Philadelphia Business Coalition on Health Women’s Health Summit, Shelly Lanning, cofounder and president of Visana Health, addressed the need for comprehensive approaches in women’s health care and their coverage options.
Read More